Traitements systémiques de première ligne en vie réelle des cancers bronchiques non à petites cellules métastatiques (CBNPCm) – Données issues de la cohorte KBP-2020-CPHG
Bulletin du Cancer · 2026-05 · 113 (5) · 619-627
DOI: 10.1016/j.bulcan.2026.01.019 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Bulletin du Cancer, 2026-05. Verfasst von Romain Corre und 6 weiteren Autor:innen. Beteiligte Einrichtung: Service de pneumologie, centre hospitalier de Cornouaille, Quimper, France. Electronic address: romain.corre@ch-cornouaille.fr. Hauptthemen laut MEDLINE: Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Immunotherapy. Die Arbeit nennt 19 Literaturangaben. Gefördert von: MSD France SAS.
Abstract (Originalsprache)
Immunotherapy has revolutionized the management of metastatic non-small cell lung cancer (NSCLC) without targetable alterations. Its use depends on histology, tumor PD-L1 expression, Performance Status (PS) score and patient age. The objective is to describe real-life therapeutic attitudes in France in 2020 and to analyze the adequacy with the professional standards applicable. The KBP-2020 study is a prospective observational study, including patients diagnosed de novo with primary lung cancer in 2020, followed in France in the participating non-university hospitals. Retrospective data analysis provides information on the first-line distribution of systemic treatments (immunotherapy, chemotherapy or the combination of both) in patients with stage IV NSCLC (542 squamous and 2082 non-squamous) without ALK rearrangement/alteration or EGFR mutations and PS score≤2. Immunotherapy alone or combined with chemotherapy is prescribed according to tumor PD-L1 expression: in case of PD-L1≥50%, in 85.2% of non-squamous and 86.6% of squamous patients, in case of PD-L1 [1-49%], in 61.7% of non-squamous and 45% of squamous patients and in case of PD-L1
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Service de pneumologie, centre hospitalier de Cornouaille, Quimper, France. Electronic address: romain.corre@ch-cornouaille.fr.
- Service de pneumologie, centre hospitalier universitaire de Rennes, Rennes, France.
- Département affaires médicales, MSD France, Puteaux, France.
- Service de pneumologie, groupe hospitalier régional de Mulhouse (GHRMSA), hôpital Émile-Muller, Mulhouse, France.
Förderung
- MSD France SAS
Zitieren
APA
Corre, R., Léna, H., Eberlin, A., Spampinato, A., Guimard, V., Dousa, S., & Debieuvre, D. (2026). Traitements systémiques de première ligne en vie réelle des cancers bronchiques non à petites cellules métastatiques (CBNPCm) – Données issues de la cohorte KBP-2020-CPHG. Bulletin du Cancer, 113(5), 619-627. https://doi.org/10.1016/j.bulcan.2026.01.019
Vancouver
Corre R, Léna H, Eberlin A, Spampinato A, Guimard V, Dousa S, et al. Traitements systémiques de première ligne en vie réelle des cancers bronchiques non à petites cellules métastatiques (CBNPCm) – Données issues de la cohorte KBP-2020-CPHG. Bulletin du Cancer. 2026;113(5):619-627. doi:10.1016/j.bulcan.2026.01.019
BibTeX
@article{Corre2026,
author = {Corre, Romain and Léna, Hervé and Eberlin, Adrien and Spampinato, Axelle and Guimard, Valérie and Dousa, Stéphanie and Debieuvre, Didier},
title = {Traitements systémiques de première ligne en vie réelle des cancers bronchiques non à petites cellules métastatiques (CBNPCm) – Données issues de la cohorte KBP-2020-CPHG},
journal = {Bulletin du Cancer},
year = {2026},
volume = {113},
number = {5},
pages = {619--627},
doi = {10.1016/j.bulcan.2026.01.019}
}
EUVIMED